These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16532456)

  • 1. Neonatal-onset multisystem inflammatory disease (NOMID) due to a novel S331R mutation of the CIAS1 gene and response to interleukin-1 receptor antagonist treatment.
    Boschan C; Witt O; Lohse P; Foeldvari I; Zappel H; Schweigerer L
    Am J Med Genet A; 2006 Apr; 140(8):883-6. PubMed ID: 16532456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases.
    Aksentijevich I; Nowak M; Mallah M; Chae JJ; Watford WT; Hofmann SR; Stein L; Russo R; Goldsmith D; Dent P; Rosenberg HF; Austin F; Remmers EF; Balow JE; Rosenzweig S; Komarow H; Shoham NG; Wood G; Jones J; Mangra N; Carrero H; Adams BS; Moore TL; Schikler K; Hoffman H; Lovell DJ; Lipnick R; Barron K; O'Shea JJ; Kastner DL; Goldbach-Mansky R
    Arthritis Rheum; 2002 Dec; 46(12):3340-8. PubMed ID: 12483741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra.
    Hawkins PN; Lachmann HJ; Aganna E; McDermott MF
    Arthritis Rheum; 2004 Feb; 50(2):607-12. PubMed ID: 14872505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition.
    Goldbach-Mansky R; Dailey NJ; Canna SW; Gelabert A; Jones J; Rubin BI; Kim HJ; Brewer C; Zalewski C; Wiggs E; Hill S; Turner ML; Karp BI; Aksentijevich I; Pucino F; Penzak SR; Haverkamp MH; Stein L; Adams BS; Moore TL; Fuhlbrigge RC; Shaham B; Jarvis JN; O'Neil K; Vehe RK; Beitz LO; Gardner G; Hannan WP; Warren RW; Horn W; Cole JL; Paul SM; Hawkins PN; Pham TH; Snyder C; Wesley RA; Hoffmann SC; Holland SM; Butman JA; Kastner DL
    N Engl J Med; 2006 Aug; 355(6):581-92. PubMed ID: 16899778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations.
    Gattorno M; Tassi S; Carta S; Delfino L; Ferlito F; Pelagatti MA; D'Osualdo A; Buoncompagni A; Alpigiani MG; Alessio M; Martini A; Rubartelli A
    Arthritis Rheum; 2007 Sep; 56(9):3138-48. PubMed ID: 17763411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryopyrin-associated periodic syndromes and autoinflammation.
    Shinkai K; McCalmont TH; Leslie KS
    Clin Exp Dermatol; 2008 Jan; 33(1):1-9. PubMed ID: 17927785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Good response to IL-1beta blockade by anakinra in a 23-year-old CINCA/NOMID patient without mutations in the CIAS1 gene. Cytokine profiles and functional studies.
    Hedrich CM; Fiebig B; Sallmann S; Bruck N; Hahn G; Roesler J; Roesen-Wolff A; Heubner G; Gahr M
    Scand J Rheumatol; 2008; 37(5):385-9. PubMed ID: 18609262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Report of a child with neonatal-onset multisystem inflammatory disease and review of the literature].
    Guan N; Li B; Wu Y
    Zhonghua Er Ke Za Zhi; 2014 Dec; 52(12):932-6. PubMed ID: 25619352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anakinra therapy for CINCA syndrome with a novel mutation in exon 4 of the CIAS1 gene.
    Matsubayashi T; Sugiura H; Arai T; Oh-Ishi T; Inamo Y
    Acta Paediatr; 2006 Feb; 95(2):246-9. PubMed ID: 16449034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and genetic heterogeneity among Spanish patients with recurrent autoinflammatory syndromes associated with the CIAS1/PYPAF1/NALP3 gene.
    Aróstegui JI; Aldea A; Modesto C; Rua MJ; Argüelles F; González-Enseñat MA; Ramos E; Rius J; Plaza S; Vives J; Yagüe J
    Arthritis Rheum; 2004 Dec; 50(12):4045-50. PubMed ID: 15593220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A somatic NLRP3 mutation as a cause of a sporadic case of chronic infantile neurologic, cutaneous, articular syndrome/neonatal-onset multisystem inflammatory disease: Novel evidence of the role of low-level mosaicism as the pathophysiologic mechanism underlying mendelian inherited diseases.
    Aróstegui JI; Lopez Saldaña MD; Pascal M; Clemente D; Aymerich M; Balaguer F; Goel A; Fournier del Castillo C; Rius J; Plaza S; López Robledillo JC; Juan M; Ibañez M; Yagüe J
    Arthritis Rheum; 2010 Apr; 62(4):1158-66. PubMed ID: 20131270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of understanding the pathogenesis and management of patients with NOMID/CINCA.
    Goldbach-Mansky R
    Curr Rheumatol Rep; 2011 Apr; 13(2):123-31. PubMed ID: 21538043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome.
    Neven B; Marvillet I; Terrada C; Ferster A; Boddaert N; Couloignier V; Pinto G; Pagnier A; Bodemer C; Bodaghi B; Tardieu M; Prieur AM; Quartier P
    Arthritis Rheum; 2010 Jan; 62(1):258-67. PubMed ID: 20039428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A variant Muckle-Wells syndrome with a novel mutation in CIAS1 gene responding to anakinra.
    Dalgic B; Egritas O; Sari S; Cuisset L
    Pediatr Nephrol; 2007 Sep; 22(9):1391-4. PubMed ID: 17486372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and genetic characterization of Italian patients affected by CINCA syndrome.
    Caroli F; Pontillo A; D'Osualdo A; Travan L; Ceccherini I; Crovella S; Alessio M; Stabile A; Gattorno M; Tommasini A; Martini A; Lepore L
    Rheumatology (Oxford); 2007 Mar; 46(3):473-8. PubMed ID: 16920754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homeostatic tissue responses in skin biopsies from NOMID patients with constitutive overproduction of IL-1β.
    Aubert P; Suárez-Fariñas M; Mitsui H; Johnson-Huang LM; Harden JL; Pierson KC; Dolan JG; Novitskaya I; Coats I; Estes J; Cowen EW; Plass N; Lee CC; Sun HW; Lowes MA; Goldbach-Mansky R
    PLoS One; 2012; 7(11):e49408. PubMed ID: 23226210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating inflammation by blocking interleukin-1 in humans.
    Dinarello CA; van der Meer JW
    Semin Immunol; 2013 Dec; 25(6):469-84. PubMed ID: 24275598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryopyrin-associated periodic syndrome: an autoinflammatory disease manifested as neutrophilic urticarial dermatosis with additional perieccrine involvement.
    Kolivras A; Theunis A; Ferster A; Lipsker D; Sass U; Dussart A; André J
    J Cutan Pathol; 2011 Feb; 38(2):202-8. PubMed ID: 21062341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current treatment recommendations and considerations for cryopyrin-associated periodic syndrome.
    Koné-Paut I; Galeotti C
    Expert Rev Clin Immunol; 2015; 11(10):1083-92. PubMed ID: 26312542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of a novel mutation in NLRP3/CIAS1 gene in an Indian child with Neonatal-Onset Multisystem Inflammatory Disease (NOMID).
    Nair SB; Chavan PP; Athalye AS; Aksentijevich I; Khubchandani RP
    Clin Rheumatol; 2019 Feb; 38(2):403-406. PubMed ID: 30066283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.